tiprankstipranks
Advertisement
Advertisement

HK:9966 Stock Latest News

Alphamab Oncology Sets AGM to Seek Share Buyback and Issuance Mandates
Company AnnouncementsAlphamab Oncology Sets AGM to Seek Share Buyback and Issuance Mandates
1d ago
9966
Alphamab Doses First Patient in Phase II Trial of JSKN033 for Advanced Cervical Cancer
PremiumCompany Announcements
Alphamab Doses First Patient in Phase II Trial of JSKN033 for Advanced Cervical Cancer
9d ago
9966
Alphamab Oncology Grants 250,000 Restricted Award Shares to Key Employees
PremiumCompany Announcements
Alphamab Oncology Grants 250,000 Restricted Award Shares to Key Employees
28d ago
9966
Alphamab Oncology Secures Waiver to Appoint Joint Company Secretary
PremiumCompany Announcements
Alphamab Oncology Secures Waiver to Appoint Joint Company Secretary
29d ago
9966
Alphamab’s KN026 Breast Cancer Trial Secures High-Profile ASCO 2026 Slot
PremiumCompany Announcements
Alphamab’s KN026 Breast Cancer Trial Secures High-Profile ASCO 2026 Slot
29d ago
9966
Alphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
PremiumCompany AnnouncementsAlphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
1M ago
9966
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
Premium
Company Announcements
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
2M ago
9966
Alphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
Premium
Company Announcements
Alphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
2M ago
9966
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
PremiumCompany Announcements
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
2M ago
9966
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
PremiumCompany Announcements
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
2M ago
9966
Alphamab Oncology Names New CFO as Capital Markets Vice President Resigns
PremiumCompany Announcements
Alphamab Oncology Names New CFO as Capital Markets Vice President Resigns
2M ago
9966
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
PremiumCompany Announcements
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
2M ago
9966
Alphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
PremiumCompany AnnouncementsAlphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
2M ago
9966
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
2M ago
9966
Alphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
Premium
Company Announcements
Alphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
2M ago
9966
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
PremiumCompany Announcements
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
4M ago
9966
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
PremiumCompany Announcements
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
5M ago
9966
Alphamab Oncology’s JSKN003 Receives FDA Breakthrough Therapy Designation
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Receives FDA Breakthrough Therapy Designation
5M ago
9966
Alphamab Oncology Advances Revolutionary JSKN027 ADC to Clinical Stage
PremiumCompany Announcements
Alphamab Oncology Advances Revolutionary JSKN027 ADC to Clinical Stage
5M ago
9966
Alphamab Oncology Initiates HK$30 Million Share Repurchase Plan
PremiumCompany AnnouncementsAlphamab Oncology Initiates HK$30 Million Share Repurchase Plan
7M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
Premium
Company Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
7M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
Premium
Company Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
7M ago
9966

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >